BioSpace News Archive

NeuroOne Medical Technologies Corporation announces its operating results for the second quarter of fiscal year 2022 ended March 31, 2022.

BIOLASE, Inc., the global leader in dental lasers, announced its financial results for the first quarter ended March 31, 2022.

Kezar Life Sciences, Inc. reported financial results for the first quarter ended March 31, 2022 and provided a business update.

Xeris Biopharma Holdings, Inc. announced it is presenting new data on the burden of illness in Cushing’s syndrome and the double-blind, placebo-controlled LOGICS study of Recorlev® in CS during the Pituitary Disorders/Neuroendocrinology ePoster sessions at the American Association of Clinical Endocrinology Annual Meeting, May 12-14, 2022.

NovaBay® Pharmaceuticals, Inc. reports financial results for the three months ended March 31, 2022 and provides a business update.

Marinus Pharmaceuticals, Inc. (Nasdaq: MRNS), a pharmaceutical company dedicated to the development of innovative therapeutics to treat seizure disorders, today reported business highlights and financial results for the first quarter ended March 31, 2022.

Cyclo Therapeutics, Inc. reported its financial results for the first quarter 2022 and provided a business update.

Chimerix announced that Josh Allen, Ph.D., Chief Technology Officer of Imipridones, will participate in a panel discussion hosted by Maxim Group.

OpGen, Inc., a precision medicine company harnessing the power of molecular diagnostics and bioinformatics to help combat infectious disease, reported its first quarter 2022 financial and operating results.

CooperCompanies, will participate in the Jefferies Healthcare Conference on Thursday, June 9, 2022.